Cell-of-Origin DNA Methylation Signatures Are Maintained during Colorectal Carcinogenesis
Felix Bormann,
Manuel Rodríguez-Paredes,
Felix Lasitschka,
Dominic Edelmann,
Tanja Musch,
Axel Benner,
Yehudit Bergman,
Sebastian M. Dieter,
Claudia R. Ball,
Hanno Glimm,
Heinz G. Linhart,
Frank Lyko
Affiliations
Felix Bormann
Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, 69120 Heidelberg, Germany
Manuel Rodríguez-Paredes
Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, 69120 Heidelberg, Germany
Felix Lasitschka
Institute of Pathology, Heidelberg University Hospital, 69120 Heidelberg, Germany
Dominic Edelmann
Division of Biostatistics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Tanja Musch
Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, 69120 Heidelberg, Germany
Axel Benner
Division of Biostatistics, German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Yehudit Bergman
Department of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University Medical School, 91120 Jerusalem, Israel
Sebastian M. Dieter
Department of Translational Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany
Claudia R. Ball
Department of Translational Medical Oncology, NCT-Dresden and DKFZ Heidelberg, 01307 Dresden, Germany
Hanno Glimm
Department of Translational Medical Oncology, NCT-Dresden and DKFZ Heidelberg, 01307 Dresden, Germany; University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany; German Cancer Consortium (DKTK), 69120 Heidelberg, Germany
Heinz G. Linhart
Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, 69120 Heidelberg, Germany; Klinik Lindau, 88131 Lindau, Germany; Department of Gastroenterology, University Hospital Freiburg, 79160 Freiburg, Germany
Frank Lyko
Division of Epigenetics, DKFZ-ZMBH Alliance, German Cancer Research Center, 69120 Heidelberg, Germany; Corresponding author
Summary: Colorectal adenomas are precursor lesions of colorectal cancers and represent clonal amplifications of single cells from colonic crypts. DNA methylation patterns specify cell-type identity during cellular differentiation and, therefore, provide opportunities for the molecular analysis of tumors. We have now analyzed DNA methylation patterns in colorectal adenomas and identified three biologically defined subclasses that describe different intestinal crypt differentiation stages. Importantly, colorectal carcinomas could be classified into the same methylation subtypes, reflecting their shared cell types of origin with adenomas. Further data analysis also revealed significantly reduced overall survival for one of the subtypes. Our results provide a concept for understanding the methylation patterns observed in colorectal cancer and provide opportunities for tumor subclassification and patient stratification. : Using DNA methylation profiling, Bormann et al. identify three DNA methylation signatures that are conserved between normal crypt sections, colorectal adenomas, and colorectal carcinomas. This suggests that cell-of-origin DNA methylation signatures are stably maintained during colorectal carcinogenesis and provides a framework for the subclassification of colorectal cancer. Keywords: DNA methylation, colorectal carcinoma, colorectal adenoma, epigenomics, cell-of-origin